TY  - GEN
AU  - Margolin,K A
TI  - Interleukin-2 in the treatment of renal cancer
SN  - 0093-7754
PY  - 2000///0424
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - immunology
KW  - Clinical Trials, Phase I as Topic
KW  - Combined Modality Therapy
KW  - Drug Administration Schedule
KW  - Humans
KW  - Interleukin-2
KW  - administration & dosage
KW  - Kidney Neoplasms
KW  - Killer Cells, Lymphokine-Activated
KW  - drug effects
KW  - Nephrectomy
KW  - Signal Transduction
KW  - Survival Rate
KW  - Thyroiditis, Autoimmune
KW  - chemically induced
N1  - Publication Type: Journal Article; Review
ER  -